Associazione Nazionale Medici Cardiologi Ospedalieri

congress.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
SAFE RENAL FUNCTION IN LONG TERM HEART TRANSPLANTED PATIENTS (SAREFU)
Anno:
2026
SA.RE.FU is a single-centre, prospective, randomized clinical trial which enrolled adult heart transplant patients in Hospital Papa Giovanni XXIII, Bergamo. The study began in 2007, with the aim to verify whether the reduction of cyclosporine dosages associated with everolimus administration may improve renal function as compared to patients maintained…
Leggi di più
FROM FIRST DIAGNOSTIC EVALUATION TO NON-DILATED LEFT VENTRICULAR CARDIOMYOPATHY: THE ADDED VALUE OF CARDIAC MAGNETIC RESONANCE
Anno:
2026
Background: Non-dilated left ventricular cardiomyopathy (NDLVC) is a heterogeneous and evolving entity, recently recognized as a distinct category in the 2023 European Society of Cardiology (ESC) Guidelines. Cardiac magnetic resonance (CMR) enables a multiparametric assessment, with myocardial strain emerging as a key functional marker. However, genotype–phenotype correlations in NDLVC…
Leggi di più
REVISITING THE 12 ML/KG/MIN THRESHOLD: CONTEMPORARY DATA CHALLENGE HEART TRANSPLANT CRITERIA
Anno:
2026
Background: Current guidelines recommend referring ambulatory heart failure (HF) patients for heart transplantation (HTX) when peak oxygen uptake (peak VO₂) is <12 mL/kg/min. This threshold, however, is based on decades-old data. As HF management has significantly improved, the relevance of this criterion in today’s clinical practice is uncertain. Methods:…
Leggi di più
EFFICACY AND TOLERABILITY OF SACUBITRIL/VALSARTAN IN DUCHENNE DYSTROPHIC CARDIOMYOPATHY: A REAL-WORLD EXPERIENCE
Anno:
2026
Background Duchenne muscular dystrophy (DMD) is an X-linked hereditary neuromuscular disorder characterized by progressive muscular weakness and the development of a dystrophic cardiomyopathy. Despite standard therapy with ACE-inhibitors (ACEi), betablockers (BB) and mineralocorticoids receptor antagonists (MRA), the progression of left ventricular dysfunction remains one of the main causes of…
Leggi di più
LEVOSIMENDAN IN PATIENTS WITH ADVANCED RENAL DYSFUNCTION: CLINICAL OUTCOMES AND TOLERABILITY IN A REAL-WORLD COHORT
Anno:
2026
Acute heart failure and cardiogenic shock are often associated with renal dysfunction. While Levosimendan can have beneficial hemodynamic effects, its off-label use in patients with eGFR<30 mL/min requires caution due to limited evidence. This study aimed to evaluate clinical outcomes and treatment tolerability of levosimendan according to renal function….
Leggi di più
RELEVANCE OF RIGHT HEART IN PATIENTS RECEIVING MCS FOR ACUTE HEART FAILURE
Anno:
2026
Introduction : Acute heart failure (AHF) is the most common emergency admission in patients above 65 years old. Pulmonary hypertension (PH) is a very common finding in AHF patients. Due to the increase of the afterload, the right ventricle (RV) increases contractility to maintain its coupling with the pulmonary…
Leggi di più
PULMONARY HYPERTENSION AS AN INDEPENDENT PROGNOSTIC DETERMINANT IN AMBULATORY PATIENTS WITH ADVANCED HEART FAILURE: A PROSPECTIVE COHORT STUDY
Anno:
2026
Background: Pulmonary hypertension (PH) complicates advanced heart failure (AdvHF) and may limit access to life-saving therapies such as heart transplantation (HTx). However, the independent prognostic value of PH in contemporary cohorts of patients with AdHF remains unclear. Methods: We prospectively enrolled ambulatory patients with at least one European Society…
Leggi di più
MECKI SCORE THRESHOLDS FOR HEART TRANSPLANTATION REFERRAL OF AMBULATORY HEART FAILURE PATIENTS
Anno:
2026
Background. In patients with chronic heart failure (HF), current guidelines recommend the use of prognostic scores to estimate survival and to support referral for heart transplantation (HTX). However, the clinical use of these tools remains limited, and no universally accepted cut-off values are currently available to guide transplant listing….
Leggi di più
INVASIVE HAEMODYNAMICS AND ADVANCED ECHOCARDIOGRAPHY TO DEFINE THE DIAGNOSTIC AND PROGNOSTIC VALUE OF LEFT ATRIAL FUNCTION IN ADVANCED HEART FAILURE
Anno:
2026
Background . Advanced heart failure (AdHF) presents challenges for haemodynamic assessment and carries a poor prognosis. Left atrial (LA) function by strain imaging has emerged as a promising non-invasive marker in several cardiovascular conditions, but its relationship with invasively measured haemodynamic parameters and its prognostic role in AdHF is…
Leggi di più
THALIDOMIDE FOR REFRACTORY ANGIODYSPLASIA-RELATED GASTROINTESTINAL BLEEDING IN A CONTINUOUS-FLOW LVAD RECIPIENT: A CASE REPORT
Anno:
2026
BACKGROUND: Gastrointestinal (GI) bleeding from intestinal angiodysplasia is a frequent complication of continuous-flow left ventricular assist device (CF-LVAD) support (≈25–30%). About 40% of patients develop recurrences, requiring rehospitalization and an elevated transfusion burden. Supraphysiologic shear stress and reduced pulsatility promote inflammatory/angiogenic mediators (TNF-α, VEGF), leading to maladaptive neovascularization and…
Leggi di più